Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Leucine-Rich Repeat Kinase 2 (LRRK2) is an enzyme encoded by the PARK8 gene. It plays a role in the retrograde trafficking pathway for recycling proteins, such as mannose 6 phosphate receptor (M6PR), between lysosomes and the Golgi apparatus in a retromer-dependent manner together with RAB29. It regulates neuronal process morphology in the intact central nervous system.
The Leucine-Rich Repeat Kinase 2 – Drugs in Development research report provides a comprehensive overview on the therapeutics under development for Leucine-Rich Repeat Kinase 2, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Leucine-rich repeat kinase 2 and features dormant and discontinued projects.
Key Therapy Areas in the Leucine-Rich Repeat Kinase 2 Pipeline Drugs Market
In the LRRK2 pipeline drugs market the key therapy areas are Central Nervous System, Cardiovascular, Gastrointestinal, Oncology, and Ophthalmology.
Leucine-Rich Repeat Kinase 2 Drugs Market, by Therapy Areas
For more therapy area insights, download a free report sample
Key MoA in the Leucine-Rich Repeat Kinase 2 Pipeline Drugs Market
Key mechanism of action in the Leucine-Rich Repeat Kinase 2 Pipeline Drugs Market is Leucine Rich Repeat Serine/Threonine Protein Kinase 2 Inhibitor.
Leucine-Rich Repeat Kinase 2 Pipeline Drugs Market Segmentation by RoA
The key routes of administration in the LRRK2 pipeline drugs market are oral, ophthalmic, and intrathecal.
Leucine-Rich Repeat Kinase 2 Pipeline Drugs Market Analysis, by RoA
To get more insights on key RoA, download a free sample report
Key Molecule Types in the Leucine-Rich Repeat Kinase 2 Pipeline Drugs Market
The key molecule types in the LRRK2 pipeline drugs market are Small Molecule, Antibody, Antisense Oligonucleotide, and Gene Therapy.
Leucine-Rich Repeat Kinase 2 Pipeline Drugs Market, by Molecule Type
To get more insights on key molecule types, download a free sample report
Major Companies in the Leucine-Rich Repeat Kinase 2 Pipeline Drugs Market
The major companies in the Leucine-Rich Repeat Kinase 2 pipeline drugs market are Denali Therapeutics Inc, D. Western Therapeutics Institute Inc, ICB International Inc, Oncodesign SA, Imago Pharmaceuticals Inc, Shape Therapeutics Inc, 1st Bio Therapeutics Inc, Ionis Pharmaceuticals Inc, Lead Discovery Center GmbH, Merck & Co Inc, and Neuron23 Inc.
Leucine-Rich Repeat Kinase 2 Pipeline Drugs Market, by Major Companies
For more company insights, download a free sample report
Leucine-Rich Repeat Kinase 2 Pipeline Drugs Market Overview
Key Therapy Areas | Central Nervous System, Cardiovascular, Gastrointestinal, Oncology, and Ophthalmology |
Key Mechanisms of action | Leucine Rich Repeat Serine/Threonine Protein Kinase 2 Inhibitor |
Key Routes of Administration | Oral, Ophthalmic, and Intrathecal |
Key molecule types | Small Molecule, Antibody, Antisense Oligonucleotide, and Gene Therapy |
Major companies | Denali Therapeutics Inc, D. Western Therapeutics Institute Inc, ICB International Inc, Oncodesign SA, Imago Pharmaceuticals Inc, Shape Therapeutics Inc, 1st Bio Therapeutics Inc, Ionis Pharmaceuticals Inc, Lead Discovery Center GmbH, Merck & Co Inc, and Neuron23 Inc |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Leucine-Rich Repeat Kinase 2
- The pipeline guide reviews pipeline therapeutics for Leucine-Rich Repeat Kinase 2 by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Leucine-Rich Repeat Kinase 2 therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Leucine-Rich Repeat Kinase 2 therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Leucine-Rich Repeat Kinase 2
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective countercstrategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Leucine-Rich Repeat Kinase 2
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Leucine-Rich Repeat Kinase 2 pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Arrien Pharmaceuticals LLC
Blue Therapeutics Inc
Cerevel Therapeutics Holdings Inc
D. Western Therapeutics Institute Inc
Denali Therapeutics Inc
E-scape Bio Inc
Guangzhou DM Intelligence Ltd
H. Lundbeck AS
Halia Therapeutics Inc
ICB International Inc
Imago Pharmaceuticals Inc
Ionis Pharmaceuticals Inc
Lead Discovery Center GmbH
Merck & Co Inc
Neuron23 Inc
Oncodesign SA
Shape Therapeutics Inc
Voronoi Group
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas in the Leucine-Rich Repeat Kinase 2 pipeline drugs market?
In the Leucine-Rich Repeat Kinase 2 pipeline drugs market the key therapy areas are Central Nervous System, Cardiovascular, Gastrointestinal, Oncology, and Ophthalmology.
-
What are the key mechanisms of action in the Leucine-Rich Repeat Kinase 2 pipeline drugs market?
In the Leucine-Rich Repeat Kinase 2 pipeline drugs market the key mechanisms of action is Leucine Rich Repeat Serine/Threonine Protein Kinase 2 Inhibitor.
-
What are the key routes of administration in the Leucine-Rich Repeat Kinase 2 pipeline drugs market?
The key routes of administration in the Leucine-Rich Repeat Kinase 2 pipeline drugs market are Oral, Ophthalmic, and Intrathecal.
-
What are the key molecule types in the Leucine-Rich Repeat Kinase 2 pipeline drugs market?
The key molecule types in the Leucine-Rich Repeat Kinase 2 pipeline drugs market are Small Molecule, Antibody, Antisense Oligonucleotide, and Gene Therapy.
-
What are the major companies in the Leucine-Rich Repeat Kinase 2 pipeline drugs market?
In the Leucine-Rich Repeat Kinase 2 pipeline drugs market the major companies are Denali Therapeutics Inc, D. Western Therapeutics Institute Inc, ICB International Inc, Oncodesign SA, Imago Pharmaceuticals Inc, Shape Therapeutics Inc, 1st Bio Therapeutics Inc, Ionis Pharmaceuticals Inc, Lead Discovery Center GmbH, Merck & Co Inc, and Neuron23 Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.